Pfizer Values Standalone Consumer Unit At $10 Bil.
This article was originally published in The Rose Sheet
Executive Summary
Pfizer is unlikely to divest individual brands from its Consumer Healthcare portfolio, leaving on the table the options of cashing out, spinning off or keeping the division, CEO Hank McKinnell indicated during a Feb. 10 analyst presentation